General Information of the Compound
Compound ID |
CP0383374
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2S)-2-[[2-[(4S)-4-[[(2S,3S)-2-[[(2S)-2-[[(2R)-2-(aminomethyl)-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-oxo-4,5-dihydro-1H-2-benzazepin-2-yl]acetyl]amino]-3-phenylpropanoic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C42H54N6O8
|
||||||||||||||||||
Molecular Weight |
770.928
|
||||||||||||||||||
Canonical SMILES |
CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](CN)C(C)C)C(=O)N[C@H]1Cc2ccccc2CN(CC(=O)N[C@@H](Cc2ccccc2)C(O)=O)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C42H54N6O8/c1-5-26(4)37(47-39(52)33(19-28-15-17-31(49)18-16-28)45-38(51)32(22-43)25(2)3)40(53)46-34-21-29-13-9-10-14-30(29)23-48(41(34)54)24-36(50)44-35(42(55)56)20-27-11-7-6-8-12-27/h6-18,25-26,32-35,37,49H,5,19-24,43H2,1-4H3,(H,44,50)(H,45,51)(H,46,53)(H,47,52)(H,55,56)/t26-,32-,33-,34-,35-,37-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
HQEOEKZNWMXPAE-UQWHTAPSSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01820, Aminopeptidase N
Protein ID: PT05116, Leucyl-cystinyl aminopeptidase
Protein ID: PT01197, Type-1 angiotensin II receptor